Skip to content

Author

C. Lebrun-Frénay

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

BACKGROUND Ofatumumab and ocrelizumab are widely used high-efficacy anti-CD20 therapies for relapsing-remitting multiple sclerosis (RRMS), but direct comparative evidence remains limited. We aimed to compare their effectiveness in routine clinical practice. METHODS We conducted an observational cohort study emulating...

Chao Zhu, S. Vukusic, T. Kalincik et al. · 0 citations
Review Open access Sep 2026

Use of patient reported outcomes in multiple sclerosis clinical management: Scoping literature review.

BACKGROUND Patient-reported outcomes (PROs) are collected in some multiple sclerosis (MS) care settings, yet their uses in MS clinical care are unclear. OBJECTIVES To determine how PROs are used in MS clinical care and gain insights into instruments, purposes, facilitators/barriers, and impact. METHODS Scoping revi...

M. Kuharic, C. Nowinski, Chelsea R. Perschon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.